France· FR:60150015
RAVICTI 1,1 g/ml, liquide oral
A medicinal product containing phénylbutyrate de glycérol, registered in France by IMMEDICA PHARMA (SUEDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PHÉNYLBUTYRATE DE GLYCÉROL
- Manufacturer
- IMMEDICA PHARMA (SUEDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300956691 flacon en verre de 25 mL avec fermeture de sécurité enfant
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phénylbutyrate de glycérol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesglycerol phenylbutyrateLupin Pharmaceuticals, Inc.
- CzechiaRAVICTIImmedica Pharma AB, Stockholm
- FinlandRAVICTIImmedica Pharma AB
- IrelandRAVICTI 1.1 g/ml oral liquidImmedica Pharma AB
- BelgiumRavicti 1.1 g/mlImmedica Pharma
- PolandRavictiImmedica Pharma AB
- SwedenRAVICTI 1,1 g/ml Oral vätskaImmedica Pharma AB
- IcelandRavictiImmedica Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ravicti
- Liechtenstein · Ravicti
- Norway · Ravicti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03a23811-8b32-4380-b46b-a84a7886d7fe GET /v1/drugs/03a23811-8b32-4380-b46b-a84a7886d7fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60150015",
"date_amm": "2015-11-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1062",
"substance": "PHÉNYLBUTYRATE DE GLYCÉROL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "liquide",
"voies_administration": "gastro-entérale;orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about phénylbutyrate de glycérol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.